Company Information

CIN
Status
Date of Incorporation
17 September 2004
State / ROC
/ ROC Hyderabad
Last Balance Sheet
31 March 2022
Last Annual Meeting
30 September 2022
Paid Up Capital
344,000,000
Authorised Capital
750,000,000

Directors

Chinnamail Santosh Reddy
Chinnamail Santosh Reddy
Director/Designated Partner
about 2 years ago
Satyanarayana Reddy Chinnamail
Satyanarayana Reddy Chinnamail
Director/Designated Partner
over 2 years ago
Khairtabad Anuraag Reddy
Khairtabad Anuraag Reddy
Director/Designated Partner
about 6 years ago
Narayan Shiva Reddy Moranganti
Narayan Shiva Reddy Moranganti
Director
about 6 years ago
Satyanarayana Reddy Khairtabad
Satyanarayana Reddy Khairtabad
Director/Designated Partner
about 21 years ago
Pratiwada Sriram Krishna Durga Prasad
Pratiwada Sriram Krishna Durga Prasad
Director
about 21 years ago

Past Directors

Kavitha Manda
Kavitha Manda
Additional Director
about 11 years ago
Alluri Durga Satya Srinivas Prasad Varma
Alluri Durga Satya Srinivas Prasad Varma
Additional Director
about 11 years ago
Vishnu Vardhana Reddy Nookala
Vishnu Vardhana Reddy Nookala
Director
about 15 years ago
Linga Reddy Churukanti
Linga Reddy Churukanti
Director
about 15 years ago
Radhakrishna Madallapalli
Radhakrishna Madallapalli
Director
about 21 years ago
Rajender Singh Sevaram
Rajender Singh Sevaram
Director
about 21 years ago

Patents

A Process For The Preparation Of Oseltamivir Phosphate

The present invention relates to a process for the preparation of Oseltamivir phosphate or tamiflu. The present invention advantageously provides an improved process with better purity and higher yield. More particularly, the present invention provides a process of synthesis of Oseltamivir phosphate starting from (1...

A Process For The Preparation Of An Intermediate Of Clopidogrel Bisulphate

The present invention relates to a process for the preparation of an intermediate of clopidogrel bisulphate, wherein the intermediate is represented by the molecular formula as (S)-methyl 2-(2-(thiophen-2-yl)ethyl amino)-2-(2-chlorophenyl)acetate hydrochloride. More particularly, the present invention relates an imp...

A Process For The Preparation Of Cytosine

The present invention is directed to a process for the preparation of cytosine. More particularly, the present invention provides a process for the preparation of cytosine without using organic solvent but with high yield and quality.

A Process For The Preparation Of (R) 3 Aminobutan 1 Ol

The present invention provides a process for the preparation of (R)-3-aminobutan-1-ol. The present invention advantageously provides an improved process with less number of impurities and higher yield. The present invention thus relates to an one pot synthesis process for preparation of (R)-3-aminobutan-1-ol employi...

Process Of Preparation Of Diamide Intermediate Of Favipiravir

The present invention provides a process for the preparation of a diamide derivative that is employed as an intermediate in the process of synthesis of Favipiravir. The present invention advantageously provides an improved two-stage process for the preparation of the said amide with lesser number of impurities and h...

Improved Process For The Preparation Of Intermediate Used In The Preparation Of Dipeptidyl Peptidase 4 (Dpp 4) Enzyme Inhibitor

ABSTRACT IMPROVED PROCESS FOR THE PREPARATION OF INTERMEDIATE USED IN THE PREPARATION OF DIPEPTIDYL PEPTIDASE-4 (DPP-4) ENZYME INHIBITOR The present invention specifically relates to an improved process for the preparation of 2,4,5-(trifluorophenyl) acetic acid compound of formula (I) used in the preparation of ...

An Improved Process For The Preparation Of Intermediates Used In The Preparation Of Rifapentine

ABSTRACT AN IMPROVED PROCESS FOR THE PREPARATION OF INTERMEDIATES USED IN THE PREPARATION OF RIFAPENTINE The present invention relates to an improved process for the preparation of intermediate compounds used in the preparation of Rifapentine. The present invention specifically relates to an improved process f...

Registered Trademarks

Arene Arene Life Sciences

[Class : 35] Trading Of Bulk Drugs & Intermediates

Arene Arene Life Sciences

[Class : 1] Chemical Additives, Chemical Preparations, Active Chemical Ingredients And Preservatives For Use In The Manufacture Of Pharmaceuticals.

Arene Lifesciences Limited Arene Life Sciences

[Class : 5] Pharmaceutical Drugs

Charges

31 August 2023
Others
0
29 October 2004
The Cosmos Co-operative Bank Limited
0
21 April 2020
Karnataka Bank Ltd.
0
29 October 2004
The Cosmos Co - Op. Bank Ltd.
0
06 October 2010
Others
0
30 December 2021
Karnataka Bank Ltd.
0
18 March 2019
Others
0
31 August 2023
Others
0
29 October 2004
The Cosmos Co-operative Bank Limited
0
21 April 2020
Karnataka Bank Ltd.
0
29 October 2004
The Cosmos Co - Op. Bank Ltd.
0
06 October 2010
Others
0
30 December 2021
Karnataka Bank Ltd.
0
18 March 2019
Others
0
08 December 2023
Hdfc Bank Limited
0
31 August 2023
Others
0
21 April 2020
Karnataka Bank Ltd.
0
29 October 2004
The Cosmos Co-operative Bank Limited
0
29 October 2004
The Cosmos Co - Op. Bank Ltd.
0
06 October 2010
Others
0
30 December 2021
Karnataka Bank Ltd.
0
18 March 2019
Others
0
08 December 2023
Hdfc Bank Limited
0
31 August 2023
Others
0
21 April 2020
Karnataka Bank Ltd.
0
29 October 2004
The Cosmos Co-operative Bank Limited
0
29 October 2004
The Cosmos Co - Op. Bank Ltd.
0
06 October 2010
Others
0
30 December 2021
Karnataka Bank Ltd.
0
18 March 2019
Others
0